Fig. 5From: The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover studyPost-exercise increase in NT-proBNP under placebo treatment. At baseline examination (p = 0.0142) and at day 90 (p = 0.0148), post-exercise values of NT-proBNP increased significantlyBack to article page